Cosmetic and topical
Skin & aging
Dipeptide diaminobutyroyl benzylamide diacetate
Evidence
Cosmetic use only
Class
Cosmetic peptide-like molecule (neuro-modulating)
KEY TAKEAWAY
This is a synthetic dipeptide-like molecule designed to imitate waglerin-1, a peptide in the venom of the Temple viper. It is sold as Syn-Ake. This is a cosmetic ingredient, not an FDA-approved drug. Cosmetics are not approved before sale, and products cannot legally claim to treat disease or change the body's structure.
Written by the Veylo editorial team · Updated
November 2026
What it is
Cosmetic peptide-like molecule (neuro-modulating)
Used for
Expression lines and wrinkles
Key fact
This is a cosmetic ingredient, not an FDA-approved drug. Cosmetics are not approved before sale, and products cannot legally claim to treat disease or change the body's structure.
Route
Applied to the skin in creams and serums
Evidence strength
Cosmetic use only
This is a synthetic dipeptide-like molecule designed to imitate waglerin-1, a peptide in the venom of the Temple viper. It is sold as Syn-Ake.
It is meant to block the acetylcholine receptor on muscle cells, which could relax the muscles behind expression lines.
This is a cosmetic ingredient, not an FDA-approved drug. Cosmetics are not approved before sale, and products cannot legally claim to treat disease or change the body's structure.
Expression lines and wrinkles.
Topical peptides are generally well tolerated, with mild irritation or allergy as the main risks. Evidence for visible results mostly comes from small studies, many supported by manufacturers.
Cosmetic ingredient with no FDA drug label. See PubMed for published studies on Dipeptide diaminobutyroyl benzylamide diacetate.
Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.